Oncology Medical News about neutropenia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended
Current Opinion in Oncology, 06/16/09

Klastersky J et al. - It is likely that the consideration of these newly recognized risk factors and the availability of more affordable granulocyte colony-stimulating factors will lead, in the near future, to an extension of the presently recognized indications for the prescription of granulocyte colony-stimulating factors.

<< Previous
Functional characteristics of apheresis-derived platelets treated...

Next >>
Pim-1 Kinase Expression Predicts Radiation Response in...